Skip to main content
EN
Caution:
At present, there are occasional discrepancies in the display of intellectual property rights holders and their representatives. We are working on a solution.
Patent Search
Details
see.ip - Details for MENSCHLICHES CD30-LIGANDANTIGEN BINDENDE PROTEINE
Details for 2018169942
Up to date per 17.06.2026
Actions
Copy link to European Patent
Download Registration Print
Details
Details for 2018169942
Title / Product Name
MENSCHLICHES CD30-LIGANDANTIGEN BINDENDE PROTEINE
Status
Granted/Registered
Protection Type
European Patent
(AT-) Application Number
2018169942
EP Publication Number
3431492
E-Number
1347632
Language
EN
PCT Number
-
Publication Date
23.01.2019 A
23.12.2020 B1
Registration Date
23.12.2020
AT Publication Date
15.01.2021
Application Date
25.04.2013
Registration Number
-
Priorities
27.04.2012
US
201261639637 P
IPC
C07K 14/28 20060101AFI20200610BHEP
Maximum Duration of Protection
25.04.2033
Owner
Novo Nordisk A/S
Novo Allé
2880 Bagsværd
DK
Amgen Inc.
One Amgen Center Drive
Thousand Oaks, California 91320-1799
US
Representative
Representative
Häupl & Ellmeyer KG, Patentanwaltskanzlei
Mariahilfer Straße 50 (Eingang Kirchengasse 1)
1070 Wien
AT
Inventor
ANDERSEN, Mette Dahl
Novo Nordisk A/S Novo Allé
2880 Bagsværd
DK
DANTZLER, Jeff
14012 Wayne Pl. N.
Seattle, WA 98133
US
ARMITAGE, Richard J.
5840 Packard Lane
Bainbridge Island, WA 98110
US
CLARK, Rutilio
5335 Old Mill Road NE
Bainbridge Island, WA 98110
US
Information about Fees
Click here to load the fees